Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review

被引:26
作者
Colombo, Carla [1 ,3 ]
De Leo, Simone [1 ]
Di Stefano, Marta [1 ]
Trevisan, Matteo [1 ]
Moneta, Claudia [1 ]
Vicentini, Leonardo [2 ]
Fugazzola, Laura [1 ,3 ]
机构
[1] IRCCS Ist Auxol Italiano, Div Endocrine & Metab Dis, Milan, Italy
[2] IRCCS Ist Auxol Italiano, Endocrine Surg Unit, Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
关键词
D O I
10.1245/s10434-020-09481-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Controversies remain about the ideal risk-based surgical approach for differentiated thyroid cancer (DTC). Methods At a single tertiary care institution, 370 consecutive patients with low- or intermediate-risk DTC were submitted to either lobectomy (LT) or total thyroidectomy (TT) and were followed up. Results Event-free survival by Kaplan-Meier curves was significantly higher after TT than after LT for the patients with either low-risk (P = 0.004) or intermediate-risk (P = 0.032) tumors. At the last follow-up visit, the prevalence of event-free patients was higher in the TT group than in the LT low-risk group (95% and 87.5%, respectively; P = 0.067) or intermediate-risk group (89% and 50%; P = 0.008). No differences in persistence prevalence were found among microcarcinomas treated by LT or TT (low risk, P = 0.938 vs. intermediate-risk, P = 0.553). Nevertheless, 15% of the low-risk and 50% of the intermediate-risk microcarcinomas treated by LT were submitted to additional treatments. On the other hand, macrocarcinomas were significantly more persistent if treated with LT than with TT (low-risk, P = 0.036 vs. intermediate-risk, P = 0.004). Permanent hypoparathyroidism was more frequent after TT (P = 0.01). After LT, thyroglobulin (Tg)/thyroid-stimulating hormone (TSH) had shown decreasing trend in 68% of the event-free patients and an increasing trend in the persistent cases. Conclusions Lobectomy can be proposed for low-risk microcarcinomas, although in a minority of cases, additional treatments are needed, and a longer follow-up period usually is required to confirm an event-free outcome compared with that for patients treated with TT. On the other hand, to achieve an excellent response, TT should be favored for intermediate-risk micro- and macro-DTCs despite the higher frequency of postsurgical complications.
引用
收藏
页码:4334 / 4344
页数:11
相关论文
共 25 条
[1]  
Appetecchia M, 2002, J EXP CLIN CANC RES, V21, P159
[2]   Aggressive Papillary Thyroid Microcarcinoma Prognostic Factors and Therapeutic Strategy [J].
Ardito, Guglielmo ;
Revelli, Luca ;
Giustozzi, Erika ;
Salvatori, Massimo ;
Fadda, Guido ;
Ardito, Francesco ;
Avenia, Nicola ;
Ferretti, Alice ;
Rampin, Lucia ;
Chondrogiannis, Sotirios ;
Colletti, Patrick M. ;
Rubello, Domenico .
CLINICAL NUCLEAR MEDICINE, 2013, 38 (01) :25-28
[3]   Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients [J].
Cho, Jae Won ;
Lee, Yu-mi ;
Lee, Yi Ho ;
Hong, Suck Joon ;
Yoon, Jong Ho .
CLINICAL ENDOCRINOLOGY, 2018, 89 (01) :100-109
[4]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214
[5]   Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated? [J].
Dobrinja, C. ;
Pastoricchio, M. ;
Troian, M. ;
Da Canal, F. ;
Bernardi, S. ;
Fabris, B. ;
de Manzini, N. .
INTERNATIONAL JOURNAL OF SURGERY, 2017, 41 :S34-S39
[6]   Long-Term Outcome after Hemithyroidectomy for Papillary Thyroid Cancer: A Comparative Study and Review of the Literature [J].
Geron, Yossi ;
Benbassat, Carlos ;
Shteinshneider, Miriam ;
Koren, Shlomit ;
Or, Keren ;
Markus, Efrat ;
Hirsch, Dania ;
Kalmovich, Limor Muallem .
CANCERS, 2019, 11 (01)
[7]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133
[8]   Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period [J].
Hay, Ian D. ;
Hutchinson, Maeve E. ;
Gonzalez-Losada, Tomas ;
McIver, Bryan ;
Reinalda, Megan E. ;
Grant, Clive S. ;
Thompson, Geoffrey B. ;
Sebo, Thomas J. ;
Goellner, John R. .
SURGERY, 2008, 144 (06) :980-987
[9]  
He QQ, 2012, AM SURGEON, V78, P1215
[10]   Long-Term Prognosis of Unilateral and Multifocal Papillary Thyroid Microcarcinoma After Unilateral Lobectomy Versus Total Thyroidectomy [J].
Jeon, Ye Won ;
Gwak, Hong Gi ;
Lim, Seung Taek ;
Schneider, Jean ;
Suh, Young Jin .
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) :2952-2958